Preclinical studies have revealed that mutations in SPOP promote genetic instability in PCa and drive prostate tumorigenesis through coordinated regulation of PI3K/mTOR and AR signaling [27]. The gene discussed is SPOP; the disease is posterior cortical atrophy.